يعرض 1,201 - 1,220 نتائج من 4,206 نتيجة بحث عن '(( significantly ((mean decrease) OR (teer decrease)) ) OR ( significant linear decrease ))', وقت الاستعلام: 0.35s تنقيح النتائج
  1. 1201
  2. 1202
  3. 1203
  4. 1204
  5. 1205
  6. 1206
  7. 1207
  8. 1208
  9. 1209
  10. 1210

    The technical route of the study. حسب Hongliang Zou (20707270)

    منشور في 2025
    "…The highest root-mean-square error recorded was 2.72m in five sequences from a multi-modal multi-scene ground robot dataset, which was significantly lower than competing approaches. …"
  11. 1211

    Point cloud fusion instance effect. حسب Hongliang Zou (20707270)

    منشور في 2025
    "…The highest root-mean-square error recorded was 2.72m in five sequences from a multi-modal multi-scene ground robot dataset, which was significantly lower than competing approaches. …"
  12. 1212

    Experimental results in the SubT-MRS dataset. حسب Hongliang Zou (20707270)

    منشور في 2025
    "…The highest root-mean-square error recorded was 2.72m in five sequences from a multi-modal multi-scene ground robot dataset, which was significantly lower than competing approaches. …"
  13. 1213
  14. 1214
  15. 1215
  16. 1216
  17. 1217

    Vertebral cancellous tissueμCT parameters are not significantly affected by aging from 16 to 21 weeks, housing type, or microgravity. حسب Rukmani Cahill (20939813)

    منشور في 2025
    "…Nonsignificant trends implicate an effect of spaceflight reducing BV/TV, increasing DA, and reducing Tb.N. Data shown are the mean ±  standard deviation with a scatter plot (ns: non-significant). …"
  18. 1218

    <i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). حسب Eudes Alves Simões-Neto (19697968)

    منشور في 2024
    "…Serological cure was achieved in 34.6% of cases, and IgG titers decreased in 15.3%.</p><p>Conclusions and significance</p><p>We encountered several barriers in managing ACD, including population vulnerability, reliance on outdated diagnostic techniques, lack of standardized molecular biology methods, and limited therapeutic options. …"
  19. 1219
  20. 1220